Compare DNP & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | DNP | HTGC |
|---|---|---|
| Founded | 1986 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Investment Managers |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.2B |
| IPO Year | N/A | 2005 |
| Metric | DNP | HTGC |
|---|---|---|
| Price | $10.05 | $19.01 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $21.13 |
| AVG Volume (30 Days) | 479.6K | ★ 1.3M |
| Earning Date | 01-01-0001 | 10-30-2025 |
| Dividend Yield | 7.88% | ★ 9.91% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.30 | 1.75 |
| Revenue | $154,887,179.00 | ★ $516,847,000.00 |
| Revenue This Year | N/A | $8.72 |
| Revenue Next Year | N/A | $9.57 |
| P/E Ratio | ★ $4.26 | $10.83 |
| Revenue Growth | 3.30 | ★ 4.54 |
| 52 Week Low | $8.69 | $15.65 |
| 52 Week High | $10.04 | $22.04 |
| Indicator | DNP | HTGC |
|---|---|---|
| Relative Strength Index (RSI) | 46.06 | 71.21 |
| Support Level | $10.00 | $17.86 |
| Resistance Level | $10.35 | $17.67 |
| Average True Range (ATR) | 0.11 | 0.30 |
| MACD | -0.02 | 0.18 |
| Stochastic Oscillator | 14.29 | 94.21 |
DNP Select Income Fund Inc is a closed-ended investment management fund. The primary investment objectives of the fund are current income and long-term growth of income. Its secondary objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing in the public utility industry.
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.